
Sign up to save your podcasts
Or


Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com
By ProSeries Media4.9
8686 ratings
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com

1,292 Listeners

543 Listeners

2,683 Listeners

1,095 Listeners

624 Listeners

169 Listeners

301 Listeners

2,166 Listeners

3,979 Listeners

962 Listeners

213 Listeners

64 Listeners

507 Listeners

689 Listeners

75 Listeners